✦ LIBER ✦
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy
✍ Scribed by Motegi, Hiroaki; Kamoshima, Yuuta; Terasaka, Shunsuke; Kobayashi, Hiroyuki; Yamaguchi, Shigeru; Tanino, Mishie; Murata, Junichi; Houkin, Kiyohiro
- Book ID
- 111930745
- Publisher
- Springer Japan
- Year
- 2012
- Tongue
- English
- Weight
- 520 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1433-7398
No coin nor oath required. For personal study only.